ADAM-17: a novel therapeutic target for triple negative breast cancer (vol 24, pg 362, 2013)

被引：0
|
作者：
McGowan, P. M.
机构：
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷 / 08期
关键词：
D O I：
10.1093/annonc/mdt285
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2199 / 2199
页数：1
相关论文
共 50 条
  • [1] ADAM-17: a novel therapeutic target for triple negative breast cancer
    McGowan, P. M.
    Mullooly, M.
    Caiazza, F.
    Sukor, S.
    Madden, S. F.
    Maguire, A. A.
    Pierce, A.
    McDermott, E. W.
    Crown, J.
    O'Donovan, N.
    Duffy, M. J.
    ANNALS OF ONCOLOGY, 2013, 24 (02) : 362 - 369
  • [2] ADAM17: A Novel Therapeutic Target for Treatment of Triple Negative Breast Cancer.
    McGowan, P. M.
    Mullooly, M.
    Sukor, S.
    Madden, S.
    McDermott, E.
    Pierce, A.
    Crown, J.
    O'Donovan, N.
    Duffy, M. J.
    CANCER RESEARCH, 2011, 71
  • [3] ADAM17: A new therapeutic target for triple negative breast cancer?
    McGowan, P.
    Mullooly, M.
    Sukor, S.
    O'Donovan, N.
    Duffy, M. J.
    EJC SUPPLEMENTS, 2010, 8 (07): : 47 - 47
  • [4] Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells (vol 112, pg 1895, 2015)
    Caiazza, F.
    Mcgowan, P. M.
    Mullooly, M.
    Murray, A.
    Synnott, N.
    O'Donovan, N.
    Flanagan, L.
    Tape, C. J.
    Murphy, G.
    Crown, J.
    Duffy, M. J.
    BRITISH JOURNAL OF CANCER, 2025,
  • [5] SLC22A17 as a novel therapeutic target for triple-negative breast cancer
    Kunnumakkara, A. B.
    Thakur, K. K.
    ANNALS OF ONCOLOGY, 2022, 33 : S139 - S139
  • [6] Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
    Caiazza, F.
    McGowan, P. M.
    Mullooly, M.
    Murray, A.
    Synnott, N.
    O'Donovan, N.
    Flanagan, L.
    Tape, C. J.
    Murphy, G.
    Crown, J.
    Duffy, M. J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (12) : 1895 - 1903
  • [7] Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells
    F Caiazza
    P M McGowan
    M Mullooly
    A Murray
    N Synnott
    N O'Donovan
    L Flanagan
    C J Tape
    G Murphy
    J Crown
    M J Duffy
    British Journal of Cancer, 2015, 112 : 1895 - 1903
  • [8] Evaluation of GABRP as a novel therapeutic target in triple negative breast cancer
    Wali, Vikram B.
    Patwardhan, Gauri A.
    Hatzis, Christos
    Pusztai, Lajos
    CANCER RESEARCH, 2017, 77
  • [9] Cripto-1 as a novel therapeutic target for triple negative breast cancer
    Castro, Nadia P.
    Fedorova-Abrams, Natalie D.
    Merchant, Anand S.
    Rangel, Maria Cristina
    Nagaoka, Tadahiro
    Karasawa, Hideaki
    Klauzinska, Malgorzata
    Hewitt, Stephen M.
    Biswas, Kajal
    Sharan, Shyam K.
    Salomon, David S.
    ONCOTARGET, 2015, 6 (14) : 11910 - 11929
  • [10] CDC20 is a novel therapeutic target in triple negative breast cancer
    Sharma, J.
    Raicu, I.
    Nguyen, J.
    Udden, N.
    Wang, Q.
    Alluri, P.
    CANCER RESEARCH, 2019, 79 (04)
12345